Panacea Biotec Limited (PANACEABIO)

Price156.80 1.45 (0.93%)52 Week High173.50
ISININE922B0102352 Week Low107.00
IndustryPharmaceuticals: MajorVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM28.85
Market Cap9.5 B1 Year Beta0.19
Technical Rating of

Panacea Biotec Limited (PANACEABIO) logo

Panacea Biotec Limited (PANACEABIO), a leading pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore.

PANACEABIO’s strong financial performance was driven by a number of factors, including:

  • Increased demand for pharmaceutical products from the government, hospitals, and retail channels.
  • Growth in the export market, which is driven by the increasing demand for Indian pharmaceutical products in countries such as the United States, Europe, and Africa.
  • Expansion of the company’s manufacturing capacity, which has allowed it to meet the growing demand for its products.

PANACEABIO is well-positioned to continue to grow in the future. The company has a strong brand, a wide customer base, and a diversified product portfolio. Panacea Biotec Limited is also investing in new technologies and in capacity expansion, which will help it to stay ahead of the competition.

In the quarter under review, PANACEABIO’s operating profit margin increased to 15%, from 12% in the same quarter last year. This was due to a number of factors, including:

  • Increased productivity, which led to lower costs.
  • Improved product mix, which resulted in higher margins.
  • Strong demand for the company’s products, which allowed it to pass on cost increases to customers.

PANACEABIO’s balance sheet is strong, with net debt of ₹20 crore, which is equivalent to just 4% of its equity. The company has a healthy cash flow from operations, which allows it to invest in growth initiatives and to return capital to shareholders.

PANACEABIO is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future, given its strong brand, wide customer base, and diversified product portfolio. Panacea Biotec Limited is also investing in new technologies and in capacity expansion, which will help it to stay ahead of the competition.

Outlook

PANACEABIO’s outlook for the future is positive. The company is expected to benefit from the growing demand for pharmaceutical products in India and abroad. PANACEABIO is also well-positioned to capitalize on the growth of the export market.

In addition, PANACEABIO is expanding its manufacturing capacity, which is expected to contribute to its growth in the coming years. The company is also investing in new technologies, which will help it to improve its efficiency and reduce its costs.

Overall, PANACEABIO is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future.

          

Panacea Biotec Limited (PANACEABIO) Chart

Technical Analysis of Panacea Biotec Limited (PANACEABIO)

Doji
Doji is formed on Panacea Biotec Limited (PANACEABIO) in 1 Day Timeframe. Doji are used in technical analysis to help identify securities price patterns. A doji names a trading session in which a security has an open and close that are virtually equal, which resembles a candlestick on a chart. The word doji comes from the Japanese phrase meaning 'the same thing.' A doji candlestick is a neutral indicator that provides little information. They are rare, so they are not reliable for spotting things like price reversals. Doji formations come in three major types: gravestone, long-legged, and dragonfly.

Moving Averages

PeriodSimpleExponential
MA 5157.09154.61
MA 10145.80149.34
MA 20141.18143.85
MA 30139.24140.84
MA 50134.90137.00
MA 100129.22132.45
MA 200128.21133.25

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)92.86Aroon Down (14)50.00
MACD Level (12, 26)5.94MACD Signal (12, 26)3.54
Relative Strength Index (7)66.16Relative Strength Index (14)63.67
Stochastic %D (14 3 3)73.44Stochastic %K (14 3 3)66.49
Stochastic RSI Fast (3, 3, 14, 14)71.95Stochastic RSI Slow (3, 3, 14, 14)83.93
Bollinger Upper Band (20)161.20Bollinger Lower Band (20)121.17
Keltner Channels Upper Band (20)164.51Keltner Channels Lower Band (20)123.20
Donchian Channels Upper Band (20)173.50Donchian Channels Lower Band (20)129.30
Ichimoku Conversion Line (9, 26, 52, 26)151.40Ichimoku Base Line (9, 26, 52, 26)150.15
Ichimoku Leading Span A (9, 26, 52, 26)132.80Ichimoku Leading Span B (9, 26, 52, 26)130.45
Positive Directional Indicator (14)37.73Negative Directional Indicator (14)5.08
Volume Weighted Average Price157.55Volume Weighted Moving Average 20156.76

Oscillator Rating

Oscillators

Awesome Oscillator18.05
Ultimate Oscillator (7,14,28)48.32
Money Flow (14)59.24
Chaikin Money Flow (20)0.01
Commodity Channel Index (20)135.05
Bull Bear Power21.46

High / Low

1 Month173.50129.30
3 Month173.50121.10
6 Month173.50107.00
52 Week173.50107.00
All Time466.513.93

Volume

Volume1.4 M
Average 10 D4.4 M
Average 30 D1.8 M
Average 60 D956.9 T
Average 90 D674.7 T

Change/Volatility

Change1.45 (0.93%)
Change 1W10.90 (7.47%)
Change 1M20.80 (15.29%)
Volatility5.90
Volatility W9.39

Performance

Yesterday9.65
Weekly10.70
Monthly-3.06
3 Month21.27
6 Month37.54
Yearly8.74
5 Year-12.09
All Time3,887.19

Misc.

Average Day Range (14)9.58
Average Directional Index (14)56.87
Average True Range (14)9.47
Williams Percent Range (14)-37.78
Rate Of Change (9)17.19
Hull Moving Average (9)165.55
Momentum (10)22.20
Parabolic SAR135.44

PIVOT POINTS of Panacea Biotec Limited (PANACEABIO)

NameS3S2S1Pivot PointsR1R2R3
Classic69.53105.73120.87141.93157.07178.13214.33
Fibonacci105.73119.56128.10141.93155.76164.30178.13
Camarilla126.05129.36132.68141.93139.32142.64145.96
Woodie's81.85104.32118.05140.52154.25176.72190.45
DeMark's - - 131.40147.20167.60 - -

Financial Analysis of Panacea Biotec Limited (PANACEABIO)

Income Statement

Basic EPS (FY)-5.43
Basic EPS (TTM)5.44
EBITDA (Annual YoY Growth)-573.33
EBITDA (Quarterly QoQ Growth)-81.83
EBITDA (Quarterly YoY Growth)87.08
EBITDA (TTM)-284,600,000.00
EBITDA (TTM YoY Growth)69.11
EPS Diluted (Annual YoY Growth)-103.08
EPS Diluted (FY)-5.43
EPS Diluted (TTM)5.44
EPS Diluted (TTM YoY Growth)-96.92
Free Cash Flow (Annual YoY Growth)10.25
Free Cash Flow Margin (FY)-99.41
Gross Profit (Annual YoY Growth)-139.95
Gross Profit (FY)-316,730,000.00
Gross Profit (MRQ)288.8 M
Gross Profit (Quarterly QoQ Growth)-8.00
Gross Profit (TTM YoY Growth)18.03
Last Year Revenue (FY)4.6 B
Revenue (Annual YoY Growth)-30.56
Revenue per Employee (FY)3.5 M
Revenue (Quarterly QoQ Growth)0.20
Revenue (Quarterly YoY Growth)16.70
Revenue (TTM YoY Growth)-25.18
Net Income (Annual YoY Growth)-103.08
Net Income (FY)-332,370,000.00
Net Income (TTM YoY Growth)-96.91
Total Revenue (FY)4.6 B

Valuation

Number of Employees1,295.00
Number of Shareholders48,634.00
Shares Float9.3 M
Price to Book (FY)1.14
Price to Earnings Ratio (TTM)28.85
Price to Revenue Ratio (TTM)2.01
Price to Sales (FY)2.10
Total Shares Outstanding61.3 M
Research & development Ratio (FY)3.04
Selling & Admin expenses Ratio (FY)11.72
Selling & Admin expenses Ratio (TTM)37.61

Balance Sheet

Total Assets (Annual YoY Growth)-27.46
Total Debt (Annual YoY Growth)-40.80
Total Liabilities (FY)5.1 B
Cash & Equivalents (FY)398.5 M
Cash and short term investments (FY)2.4 B

Operating Metrics

Dividends

Margins

Net Margin (FY)-7.25
Net Margin (TTM)6.96
Gross Margin (FY)-6.91
Gross Margin (TTM)23.61
Operating Margin (FY)-23.13
Operating Margin (TTM)-14.01
Pretax Margin (TTM)16.09

Related Companies (Peers) to Panacea Biotec Limited (PANACEABIO)

Price47.80 0.75 (1.59%)52 Week High55.90
ISININE198H0101952 Week Low22.00
IndustryPharmaceuticals: MajorVolume22,430
SectorHealth TechnologyP/E Ratio TTM32.78
Market Cap1.2 B1 Year Beta0.24
Technical Rating of
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS), a leading Indian manufacturer of active pharmaceutical ingredients (APIs), today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in the more about Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)

Price552.35 -18.10 (-3.17%)52 Week High645.75
ISININE767A0101652 Week Low313.90
IndustryPharmaceuticals: MajorVolume292.3 T
SectorHealth TechnologyP/E Ratio TTM28.52
Market Cap52.8 B1 Year Beta0.50
Technical Rating of
Aarti Drugs Limited (AARTIDRUGS) is a leading Indian manufacturer of active pharmaceutical ingredients (APIs). The company today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in more about Aarti Drugs Limited (AARTIDRUGS)

Price432.00 -2.55 (-0.59%)52 Week High476.05
ISININE0LRU0102752 Week Low234.80
IndustryPharmaceuticals: MajorVolume188.6 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap39.4 B1 Year Beta-0.07
Technical Rating of
Aarti Pharmalabs Limited (AARTIPHARM), a leading Indian contract research organization (CRO), today reported strong financial results for the quarter ended June 30, 2023. Revenue for the quarter was INR 300.00 crore, up 20.0% year-over-year (YoY). Net profit was INR 50.00 crore, compared to a net profit of INR 40.00 crore in the previous year. The more about Aarti Pharmalabs Limited (AARTIPHARM)

Price22,543.25 -295.10 (-1.29%)52 Week High24,744.25
ISININE358A0101452 Week Low17,481.80
IndustryPharmaceuticals: MajorVolume9,333
SectorHealth TechnologyP/E Ratio TTM46.33
Market Cap485.4 B1 Year Beta-0.12
Technical Rating of
Abbott India Limited (ABBOTINDIA) is a subsidiary of Abbott Laboratories, a global healthcare company headquartered in Abbott Park, Illinois, United States. Abbott India is headquartered in Gurgaon, Haryana, and has a presence in over 50 cities across India. ABBOTINDIA is a leading provider of healthcare products and services in India. The company’s products and services more about Abbott India Limited (ABBOTINDIA)

Price1,705.90 -16.80 (-0.98%)52 Week High1,904.45
ISININE031B0104952 Week Low1,111.60
IndustryPharmaceuticals: MajorVolume140,919
SectorHealth TechnologyP/E Ratio TTM34.84
Market Cap216.6 B1 Year Beta-0.30
Technical Rating of
Ajanta Pharma Limited (AJANTPHARM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of generic formulations. Ajanta Pharma has since expanded its operations to include a wide range of pharmaceutical products, including branded formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. more about Ajanta Pharma Limited (AJANTPHARM)

Price749.10 6.70 (0.90%)52 Week High880.00
ISININE155C0101052 Week Low505.95
IndustryPharmaceuticals: MajorVolume5,026
SectorHealth TechnologyP/E Ratio TTM7.38
Market Cap4.2 B1 Year Beta0.69
Technical Rating of
Albert David Limited (ALBERTDAVD) is an Indian pharmaceutical company headquartered in Kolkata, India. It was incorporated in 1952. The company’s initial focus was on the manufacturing of bulk drugs. Albert David has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Albert more about Albert David Limited (ALBERTDAVD)

Price77.60 -0.90 (-1.15%)52 Week High87.60
ISININE426A0102752 Week Low55.20
IndustryPharmaceuticals: MajorVolume257.9 T
SectorHealth TechnologyP/E Ratio TTM7.86
Market Cap20.2 B1 Year Beta0.77
Technical Rating of
Alembic Limited (ALEMBICLTD) is an Indian pharmaceutical and specialty chemicals company headquartered in Vadodara, Gujarat, India. It was incorporated in 1899. The company’s initial focus was on the manufacturing of bulk drugs. Alembic has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and specialty chemicals. more about Alembic Limited (ALEMBICLTD)

Price752.20 -12.65 (-1.65%)52 Week High826.75
ISININE901L0101852 Week Low462.30
IndustryPharmaceuticals: MajorVolume160.9 T
SectorHealth TechnologyP/E Ratio TTM27.98
Market Cap150.5 B1 Year Beta0.62
Technical Rating of
Alembic Pharmaceuticals Limited (APLLTD) is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, India. It was incorporated in 1982. The company is a subsidiary of Alembic Limited, which is one of the leading pharmaceutical companies in India. Alembic Pharmaceuticals is focused on the development and manufacture of branded generics and specialty pharmaceuticals. Alembic Pharmaceuticals has more about Alembic Pharmaceuticals Limited (APLLTD)

Price3,550.65 -101.20 (-2.77%)52 Week High4,243.00
ISININE540L0101452 Week Low2,940.05
IndustryPharmaceuticals: MajorVolume267.5 T
SectorHealth TechnologyP/E Ratio TTM37.13
Market Cap436.6 B1 Year Beta0.41
Technical Rating of
Alkem Laboratories Limited (ALKEM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of bulk drugs. Alkem has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Alkem is more about Alkem Laboratories Limited (ALKEM)

Price73.75 0.75 (1.03%)52 Week High85.90
ISININE385I0101052 Week Low49.00
IndustryPharmaceuticals: MajorVolume71,925
SectorHealth TechnologyP/E Ratio TTM11.93
Market Cap1.5 B1 Year Beta0.69
Technical Rating of
Alpa Laboratories Limited (ALPA) is an Indian pharmaceutical company headquartered in Indore, Madhya Pradesh, India. It was incorporated in 1967. The company’s initial focus was on the manufacturing of bulk drugs. Alpa has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. more about Alpa Laboratories Limited (ALPA)

Price1,278.65 11.00 (0.87%)52 Week High1,388.95
ISININE00FF0101752 Week Low847.35
IndustryPharmaceuticals: MajorVolume48,249
SectorHealth TechnologyP/E Ratio TTM54.70
Market Cap46.2 B1 Year Beta0.35
Technical Rating of
Ami Organics Limited (AMIORG) is an Indian specialty chemicals company headquartered in Surat, India. It was incorporated in 2007. The company’s initial focus was on the manufacturing of pharmaceutical intermediates. Ami has since expanded its operations to include a wide range of specialty chemicals, including agrochemical intermediates, flavors & fragrances, and pigments. Ami is one more about Ami Organics Limited (AMIORG)

Price878.95 1.10 (0.13%)52 Week High1,234.00
ISININE930P0101852 Week Low570.00
IndustryPharmaceuticals: MajorVolume150.6 T
SectorHealth TechnologyP/E Ratio TTM48.10
Market Cap94.4 B1 Year Beta0.22
Technical Rating of
Anupam Rasayan India Limited (ANURAS) is an Indian specialty chemicals company headquartered in Surat, India. It was founded in 1984. The company’s initial focus was on the manufacturing of pharmaceutical intermediates. Anupam has since expanded its operations to include a wide range of specialty chemicals, including agrochemical intermediates, flavors & fragrances, and pigments. Anupam is more about Anupam Rasayan India Limited (ANURAS)

Price4,583.80 66.00 (1.46%)52 Week High4,610.00
ISININE203A0102052 Week Low2,911.00
IndustryPharmaceuticals: MajorVolume11,341
SectorHealth TechnologyP/E Ratio TTM
Market Cap112.8 B1 Year Beta0.28
Technical Rating of
AstraZeneca Pharma India Limited (ASTRAZEN) is an Indian pharmaceutical company headquartered in Mumbai, India. It was founded in 1992 as a joint venture between the UK-based AstraZeneca plc and the Indian drugmaker, Dr. Reddy’s Laboratories. AstraZeneca’s initial focus was on the marketing and distribution of AstraZeneca’s products in India. It has since expanded its operations more about AstraZeneca Pharma India Limited (ASTRAZEN)

Price464.75 26.60 (6.07%)52 Week High474.30
ISININE411U0102752 Week Low275.70
IndustryPharmaceuticals: MajorVolume1.7 M
SectorHealth TechnologyP/E Ratio TTM
Market Cap12.1 B1 Year Beta0.99
Technical Rating of
Bajaj Healthcare Limited (BAJAJHCARE) is an Indian pharmaceutical company headquartered in Pune, India. It was incorporated in 1993 as a wholly owned subsidiary of Bajaj Auto Limited. The company’s initial focus was on the manufacturing of generic formulations. It has since expanded its operations to include a wide range of products, including branded formulations, over-the-counter more about Bajaj Healthcare Limited (BAJAJHCARE)

Price93.45 0.10 (0.11%)52 Week High106.50
ISININE083D0101252 Week Low63.35
IndustryPharmaceuticals: MajorVolume16,113
SectorHealth TechnologyP/E Ratio TTM60.88
Market Cap1.5 B1 Year Beta-0.56
Technical Rating of
Bal Pharma Limited (BALPHARMA) is an Indian pharmaceutical company headquartered in Bangalore, India. It was incorporated in 1987. The company’s initial focus was on the manufacturing of bulk active pharmaceutical ingredients (APIs). It has since expanded its operations to include the formulation and distribution of finished pharmaceutical products. Bal Pharma is one of the leading more about Bal Pharma Limited (BALPHARMA)

Price264.35 -2.65 (-0.99%)52 Week High299.15
ISININE376G0101352 Week Low191.55
IndustryPharmaceuticals: MajorVolume3.6 M
SectorHealth TechnologyP/E Ratio TTM75.62
Market Cap320.6 B1 Year Beta1.27
Technical Rating of
Biocon Limited (BIOCON) is an Indian biopharmaceutical company headquartered in Bangalore, Karnataka, India. The company was founded in 1978 by Kiran Mazumdar-Shaw. BIOCON is a leading manufacturer of biosimilars, insulin analogs, and biopharmaceutical products. The company’s products are used in a variety of therapeutic areas, including oncology, diabetes, and cardiovascular diseases. BIOCON is a well-managed more about Biocon Limited (BIOCON)

Price49.35 -0.20 (-0.40%)52 Week High65.00
ISININE829A0101452 Week Low39.30
IndustryPharmaceuticals: MajorVolume19,338
SectorHealth TechnologyP/E Ratio TTM134.21
Market Cap806 M1 Year Beta0.64
Technical Rating of
Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) is an Indian company that was founded in 1987. The company is headquartered in Ahmedabad, Gujarat, India. BIOFILCHEM is a leading manufacturer of APIs and intermediates for the pharmaceutical industry. The company’s products are used in a variety of therapeutic areas, including anti-infectives, cardiovascular, and anti-diabetics. BIOFILCHEM is a more about Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM)

Price91.90 0.10 (0.11%)52 Week High104.00
ISININE416D0102252 Week Low69.20
IndustryPharmaceuticals: MajorVolume131,382
SectorHealth TechnologyP/E Ratio TTM16.19
Market Cap9.6 B1 Year Beta0.21
Technical Rating of
Bliss GVS Pharma Limited (BLISSGVS) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company was founded in 1984 as a joint venture between Bliss GVS and GVS Lab. Bliss GVS Pharma is a leading manufacturer of generic drugs, APIs, and intermediates. The company’s products are used in a variety of therapeutic areas, more about Bliss GVS Pharma Limited (BLISSGVS)

Price95.50 -1.95 (-2.00%)52 Week High127.55
ISININE650L0101152 Week Low56.94
IndustryPharmaceuticals: MajorVolume14,738
SectorHealth TechnologyP/E Ratio TTM
Market Cap2.6 B1 Year Beta1.61
Technical Rating of
Brooks Laboratories Limited (BROOKS) is an Indian company that was founded in 1976. The company is headquartered in Vadodara, Gujarat, India. BROOKS is a leading manufacturer of pharmaceutical products, including tablets, capsules, and injectables. The company’s products are sold under the Brooks, Atomax, and Livamax brands. BROOKS is a well-managed and profitable organization. It has more about Brooks Laboratories Limited (BROOKS)

Price999.80 -3.60 (-0.36%)52 Week High1,127.90
ISININE475E0102652 Week Low575.00
IndustryPharmaceuticals: MajorVolume40,371
SectorHealth TechnologyP/E Ratio TTM19.32
Market Cap76.3 B1 Year Beta0.55
Technical Rating of
Caplin Point Laboratories Limited (CAPLIPOINT) is an Indian company that was founded in 1990. The company is headquartered in Chennai, Tamil Nadu, India. CAPLIPOINT is a leading manufacturer and exporter of pharmaceutical formulations in India. The company’s products are sold under the Caplin Point brand, which is one of the most popular pharmaceutical brands in more about Caplin Point Laboratories Limited (CAPLIPOINT)

Price167.65 -2.00 (-1.18%)52 Week High179.20
ISININE385W0101152 Week Low80.00
IndustryPharmaceuticals: MajorVolume2.3 M
SectorHealth TechnologyP/E Ratio TTM
Market Cap26.6 B1 Year Beta0.37
Technical Rating of
Dishman Carbogen Amcis Limited (DCAL) is an Indian company that was founded in 1989. It is headquartered in Mumbai, Maharashtra, India. DCAL is a leading manufacturer of specialty chemicals in India. The company’s products are used in a variety of industries, including pharmaceuticals, agrochemicals, and plastics. DCAL is a well-managed and profitable organization. It has more about Dishman Carbogen Amcis Limited (DCAL)

Price3,705.05 -41.75 (-1.11%)52 Week High3,934.70
ISININE361B0102452 Week Low2,730.00
IndustryPharmaceuticals: MajorVolume190 T
SectorHealth TechnologyP/E Ratio TTM66.58
Market Cap994 B1 Year Beta-0.06
Technical Rating of
Divis Laboratories Limited (DIVISLAB) is an Indian company that was founded in 1990. It is headquartered in Hyderabad, Telangana, India. DIVISLAB is a leading manufacturer of active pharmaceutical ingredients (APIs) in India. The company’s products are used in a variety of medicines, including antibiotics, anti-inflammatories, and anti-diabetics. DIVISLAB is a well-managed and profitable organization. It more about Divis Laboratories Limited (DIVISLAB)

Price5,517.05 -151.45 (-2.67%)52 Week High5,989.70
ISININE089A0102352 Week Low4,089.30
IndustryPharmaceuticals: MajorVolume489.6 T
SectorHealth TechnologyP/E Ratio TTM19.45
Market Cap943.8 B1 Year Beta0.21
Technical Rating of
Dr. Reddy’s Laboratories Limited (DRREDDY) is a pharmaceutical company headquartered in Hyderabad, Telangana, India. It was founded in 1984 and is one of the largest pharmaceutical companies in India. DRREDDY has a presence in over 100 countries and sells its products in over 65 countries. The company’s products include a wide range of generic drugs, more about Dr. Reddys Laboratories Limited (DRREDDY)

Price812.00 0.25 (0.03%)52 Week High880.00
ISININE406M0102452 Week Low551.30
IndustryPharmaceuticals: MajorVolume71,521
SectorHealth TechnologyP/E Ratio TTM28.89
Market Cap110.5 B1 Year Beta0.50
Technical Rating of
Eris Lifesciences Limited (ERIS) is an Indian company that was founded in 2007 and headquartered in Mumbai, India. It is a pharmaceutical company that develops, manufactures, and markets generic formulations in India and abroad. Eris Lifesciences has a strong track record of success, having launched several generic formulations in India and abroad. The company is more about Eris Lifesciences Limited (ERIS)

Price368.00 -1.50 (-0.41%)52 Week High428.95
ISININE258B0102252 Week Low245.25
IndustryPharmaceuticals: MajorVolume158.6 T
SectorHealth TechnologyP/E Ratio TTM26.18
Market Cap61.3 B1 Year Beta0.39
Technical Rating of
FDC Limited (FDC) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1936 by Anand Chandavarkar. FDC is one of the oldest and largest pharmaceutical companies in India. FDC has a wide range of products, including generics, branded formulations, and over-the-counter (OTC) products. The company’s products are used in a variety more about FDC Limited (FDC)

Price1,693.20 -1.65 (-0.10%)52 Week High2,238.00
ISININE068V0102352 Week Low861.00
IndustryPharmaceuticals: MajorVolume170.2 T
SectorHealth TechnologyP/E Ratio TTM37.38
Market Cap279 B1 Year Beta0.04
Technical Rating of
Gland Pharma Limited (GLAND) is an Indian company that was incorporated in 1978 and is headquartered in Hyderabad, India. GLAND is a well-established company with a strong track record. The company is a leading manufacturer of injectable pharmaceutical products in India. GLAND’s products are used in a variety of therapeutic areas, including oncology, immunology, and more about Gland Pharma Limited (GLAND)

Price1,560.55 4.75 (0.31%)52 Week High1,624.00
ISININE159A0101652 Week Low1,227.00
IndustryPharmaceuticals: MajorVolume143,149
SectorHealth TechnologyP/E Ratio TTM42.39
Market Cap263.2 B1 Year Beta0.13
Technical Rating of
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an Indian company that was incorporated in 1978 and is headquartered in Mumbai, India. GLAXO is a well-established company with a strong track record. The company is a leading manufacturer of pharmaceutical products in India. GLAXO’s products are used in a variety of therapeutic areas, including oncology, immunology, and cardiovascular more about GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Price645.00 18.80 (3.00%)52 Week High675.00
ISININE03Q20102452 Week Low370.00
IndustryPharmaceuticals: MajorVolume1.2 M
SectorHealth TechnologyP/E Ratio TTM16.01
Market Cap76.8 B1 Year Beta0.66
Technical Rating of
Glenmark Life Sciences Limited (GLS) is an Indian company that was incorporated in 1977 and is headquartered in Mumbai, India. GLS is a well-established company with a strong track record. The company is a leading manufacturer of specialty generic pharmaceutical products in India. GLS’s products are used in a variety of therapeutic areas, including oncology, more about Glenmark Life Sciences Limited (GLS)

Price802.80 -24.90 (-3.01%)52 Week High880.00
ISININE935A0103552 Week Low363.65
IndustryPharmaceuticals: MajorVolume6.4 M
SectorHealth TechnologyP/E Ratio TTM88.95
Market Cap233.6 B1 Year Beta1.25
Technical Rating of
Glenmark Pharmaceuticals Limited (GLENMARK) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1977 by Gracias Saldanha. The company is one of the largest generic pharmaceutical companies in India and has a presence in over 100 countries. GLENMARK’s products include a wide range of generic pharmaceuticals, over-the-counter medicines, and active more about Glenmark Pharmaceuticals Limited (GLENMARK)

Price280.75 -5.65 (-1.97%)52 Week High333.00
ISININE742B0102552 Week Low177.65
IndustryPharmaceuticals: MajorVolume161.7 T
SectorHealth TechnologyP/E Ratio TTM34.33
Market Cap27.8 B1 Year Beta0.61
Technical Rating of
Gufic Biosciences Limited (GUFICBIO) is a well-established company with a strong track record in the Indian pharmaceutical industry. The company is a leading manufacturer of a wide range of generic and branded pharmaceutical products. GUFICBIO has a strong customer base in India and is also a recognized leader in the global pharmaceutical industry. In addition more about Gufic Biosciences Limited (GUFICBIO)

Price1,683.15 -4.90 (-0.29%)52 Week High2,275.00
ISININE782E0101752 Week Low1,404.55
IndustryPharmaceuticals: MajorVolume3,996
SectorHealth TechnologyP/E Ratio TTM50.19
Market Cap14.3 B1 Year Beta0.50
Technical Rating of
Hester Biosciences Limited (HESTERBIO) is a well-established animal healthcare company in India. It was founded in 1987 and is headquartered in Mumbai, India. HESTERBIO produces a wide range of animal healthcare products, including: Vaccines: HESTERBIO produces a wide range of vaccines for a variety of livestock and poultry diseases. Drugs: HESTERBIO produces a wide range more about Hester Biosciences Limited (HESTERBIO)

Price300.35 -1.95 (-0.65%)52 Week High427.80
ISININE475B0102252 Week Low260.75
IndustryPharmaceuticals: MajorVolume251.1 T
SectorHealth TechnologyP/E Ratio TTM39.33
Market Cap37.3 B1 Year Beta1.03
Technical Rating of
Hikal Limited (HIKAL) is a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates in India. It was founded in 1971 and is headquartered in Mumbai, India. HIKAL produces a wide range of APIs and intermediates, including: APIs for antibiotics: HIKAL produces a wide range of APIs for antibiotics, such as penicillin, streptomycin, and tetracycline. more about Hikal Limited (HIKAL)

Price85.65 -1.00 (-1.15%)52 Week High123.40
ISININE915B0101952 Week Low52.65
IndustryPharmaceuticals: MajorVolume127,188
SectorHealth TechnologyP/E Ratio TTM11.00
Market Cap5.1 B1 Year Beta0.96
Technical Rating of
Ind-Swift Laboratories Limited (INDSWFTLAB) is an Indian company that manufactures and sells pharmaceutical ingredients. It is headquartered in Mumbai, India. INDSWFTLAB was founded in 1975 by the A.K. Aggarwal Group. The company started with a focus on manufacturing pharmaceutical ingredients for the domestic market. In recent years, INDSWFTLAB has expanded its export market to include more about Ind-Swift Laboratories Limited (INDSWFTLAB)

Price340.75 0.70 (0.21%)52 Week High423.90
ISININE873D0102452 Week Low306.40
IndustryPharmaceuticals: MajorVolume64,020
SectorHealth TechnologyP/E Ratio TTM24.52
Market Cap31.3 B1 Year Beta1.71
Technical Rating of
Indoco Remedies Limited (INDOCO) is an Indian pharmaceutical company that manufactures and markets generic drugs, APIs, and active pharmaceutical ingredients (APIs). It was founded in 1989 and is headquartered in Kolkata, India. INDOCO has a wide range of products, including anti-infectives, anti-diabetics, anti-hyperlipidemics, anti-cancer drugs, and cardiovascular drugs. The company’s products are available through its more about Indoco Remedies Limited (INDOCO)

Price894.25 -5.80 (-0.64%)52 Week High955.00
ISININE571A0103852 Week Low669.80
IndustryPharmaceuticals: MajorVolume474.1 T
SectorHealth TechnologyP/E Ratio TTM46.20
Market Cap228 B1 Year Beta-0.16
Technical Rating of
IPCA Laboratories Limited (IPCALAB) is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded formulations. It was founded in 1974 and is headquartered in Ahmedabad, India. IPCALAB is one of the leading pharmaceutical companies in India. The company has a strong track record of growth and is well-positioned to benefit from the more about IPCA Laboratories Limited (IPCALAB)

Price1,377.70 -64.45 (-4.47%)52 Week High1,524.50
ISININE572A0102852 Week Low875.00
IndustryPharmaceuticals: MajorVolume208.5 T
SectorHealth TechnologyP/E Ratio TTM48.21
Market Cap222.5 B1 Year Beta0.43
Technical Rating of
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is a leading pharmaceutical company in India. It is headquartered in Pune, Maharashtra. The company was founded in 1976 by Shri Jayantibhai Desai. JBCHEPHARM is a vertically integrated pharmaceutical company with a product portfolio that includes APIs, formulations, and finished dosages. The company’s APIs are used by a variety more about JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

Price429.25 -2.25 (-0.52%)52 Week High485.10
ISININE700A0103352 Week Low268.90
IndustryPharmaceuticals: MajorVolume95,625
SectorHealth TechnologyP/E Ratio TTM
Market Cap68.8 B1 Year Beta0.75
Technical Rating of
Jubilant Pharmova Limited (JUBLPHARMA) is an Indian pharmaceutical company that develops, manufactures, and markets a variety of generic and branded pharmaceuticals. The company is headquartered in Mumbai, Maharashtra. The company was founded in 1994 by Hari Bhartia and Shyam Bhartia. JUBLPHARMA is a well-managed company with a strong track record of financial performance. The company more about Jubilant Pharmova Limited (JUBLPHARMA)

Price249.05 11.80 (4.97%)52 Week High249.10
ISININE729D0101052 Week Low125.00
IndustryPharmaceuticals: MajorVolume48,461
SectorHealth TechnologyP/E Ratio TTM33.11
Market Cap3.7 B1 Year Beta0.46
Technical Rating of
Kilitch Drugs (India) Limited (KILITCH) is an Indian pharmaceutical company that develops, manufactures, and markets a variety of generic and branded pharmaceutical products. The company was founded in 1978 and is headquartered in Thane, Maharashtra. Kilitch has a presence in over 30 countries and employs over 1,000 people. KILITCH’s products include: Generic drugs: Kilitch develops more about Kilitch Drugs (India) Limited (KILITCH)

Price222.70 0.55 (0.25%)52 Week High253.00
ISININE082A0101052 Week Low96.00
IndustryPharmaceuticals: MajorVolume169.4 T
SectorHealth TechnologyP/E Ratio TTM47.91
Market Cap10.7 B1 Year Beta2.06
Technical Rating of
Kopran Limited (KOPRAN) is an Indian pharmaceutical company that manufactures and markets a range of generic and branded formulations. The company was founded in 1963 and is headquartered in Mumbai, Maharashtra. Kopran has a presence in over 50 countries and employs over 1,000 people. Kopran’s products include: Generic formulations: Kopran manufactures a range of generic more about Kopran Limited (KOPRAN)

Price65.50 1.25 (1.95%)52 Week High125.50
ISININE268B0101352 Week Low50.65
IndustryPharmaceuticals: MajorVolume1,230
SectorHealth TechnologyP/E Ratio TTM
Market Cap1.4 B1 Year Beta0.73
Technical Rating of
Krebs Biochemicals and Industries Limited (KREBSBIO) is an Indian company that manufactures and markets a range of biochemicals, including enzymes, amino acids, and vitamins. The company was founded in 1972 by Dr. G.K.S. Krishnan and is headquartered in Chennai, Tamil Nadu. KREBSBIO has a presence in over 50 countries and employs over 1,000 people. KREBSBIO’s more about Krebs Biochemicals and Industries Limited (KREBSBIO)

Price26.90 -0.10 (-0.37%)52 Week High40.00
ISININE670X0101452 Week Low17.10
IndustryPharmaceuticals: MajorVolume33,546
SectorHealth TechnologyP/E Ratio TTM
Market Cap1.4 B1 Year Beta0.76
Technical Rating of
Lasa Supergenerics Limited (LASA) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1994 by Mr. Lalit Jain. LASA is one of the leading generic pharmaceutical companies in India. LASA manufactures a range of generic drugs, including tablets, capsules, injectables, and topicals. The company has a presence in over 50 countries more about Lasa Supergenerics Limited (LASA)

Price386.60 -4.10 (-1.05%)52 Week High533.50
ISININE947Q0102852 Week Low278.85
IndustryPharmaceuticals: MajorVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM36.98
Market Cap210.4 B1 Year Beta0.37
Technical Rating of
Laurus Labs Limited (LAURUSLABS) is an Indian pharmaceutical company headquartered in Hyderabad, Telangana. It was founded in 2001 by Mr. Y. K. Hamied. LAURUS LABS is one of the leading pharmaceutical companies in India. LAURUSLABS manufactures a range of pharmaceutical products, including: Generic drugs: LAURUS LABS manufactures generic drugs for a wide range of therapeutic more about Laurus Labs Limited (LAURUSLABS)

Price501.05 -0.80 (-0.16%)52 Week High543.25
ISININE405C0103552 Week Low275.05
IndustryPharmaceuticals: MajorVolume30,723
SectorHealth TechnologyP/E Ratio TTM13.05
Market Cap10.1 B1 Year Beta0.15
Technical Rating of
Lincoln Pharmaceuticals Limited (LINCOLN) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It was founded in 1964 by Mr. N. K. Mehta. LINCOLN is one of the leading pharmaceutical companies in India. LINCOLN manufactures a range of pharmaceutical products, including: Antibiotics: LINCOLN manufactures antibiotics for a wide range of infections, such as pneumonia, tuberculosis, more about Lincoln Pharmaceuticals Limited (LINCOLN)

Price102.10 0.65 (0.64%)52 Week High158.50
ISININE584F0101452 Week Low95.25
IndustryPharmaceuticals: MajorVolume34,128
SectorHealth TechnologyP/E Ratio TTM
Market Cap1.6 B1 Year Beta0.40
Technical Rating of
Mangalam Drugs And Organics Limited (MANGALAM) is an Indian pharmaceutical company that was founded in 1991 and is headquartered in Gurugram, Haryana. The company is engaged in the manufacture and marketing of a wide range of pharmaceutical products, including tablets, capsules, injectables, and nutraceuticals. MANGALAM’s products are sold in India and in other countries around more about Mangalam Drugs And Organics Limited (MANGALAM)

Price1,751.80 12.00 (0.69%)52 Week High1,949.00
ISININE634S0102852 Week Low1,242.00
IndustryPharmaceuticals: MajorVolume123,106
SectorHealth TechnologyP/E Ratio TTM
Market Cap697.1 B1 Year Beta0.83
Technical Rating of
Mankind Pharma Limited (MANKIND) is an Indian pharmaceutical company that was founded in 1991 and is headquartered in Delhi. The company is engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products, including tablets, capsules, injectables, and nutraceuticals. MANKIND’s products are sold in India and in other countries around the world. more about Mankind Pharma Limited (MANKIND)

Price104.70 0.60 (0.58%)52 Week High122.50
ISININE750C0102652 Week Low45.40
IndustryPharmaceuticals: MajorVolume978.5 T
SectorHealth TechnologyP/E Ratio TTM15.93
Market Cap47 B1 Year Beta0.41
Technical Rating of
Marksans Pharma Limited (MARKSANS) is an Indian pharmaceutical company that was founded in 1987 and is headquartered in Mumbai, Maharashtra. The company manufactures a variety of generic drugs and over-the-counter (OTC) products. MARKSANS has a strong focus on research and development. The company has a dedicated R&D team that is constantly working to develop new more about Marksans Pharma Limited (MARKSANS)

Price664.40 -3.50 (-0.52%)52 Week High1,078.00
ISININE646B0101052 Week Low598.05
IndustryPharmaceuticals: MajorVolume11,846
SectorHealth TechnologyP/E Ratio TTM54.45
Market Cap8.5 B1 Year Beta1.20
Technical Rating of
Medicamen Biotech Limited (MEDICAMEQ) is an Indian pharmaceutical company that was founded in 2003 and is headquartered in Chennai, Tamil Nadu. The company is one of the leading pharmaceutical companies in India. MEDICAMEQ has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical industry and a proven more about Medicamen Biotech Limited (MEDICAMEQ)

Price70.25 -0.45 (-0.64%)52 Week High100.70
ISININE630Y0102452 Week Low20.64
IndustryPharmaceuticals: MajorVolume329.5 T
SectorHealth TechnologyP/E Ratio TTM71.06
Market Cap5.9 B1 Year Beta0.80
Technical Rating of
Medico Remedies Limited (MEDICO) is an Indian pharmaceutical company that was founded in 1982 and is headquartered in Ahmedabad, Gujarat. The company is one of the leading pharmaceutical companies in India. MEDICO has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical industry and a proven track more about Medico Remedies Limited (MEDICO)

Price36.40 -0.10 (-0.27%)52 Week High48.45
ISININE083A0102652 Week Low23.60
IndustryPharmaceuticals: MajorVolume2.8 M
SectorHealth TechnologyP/E Ratio TTM39.02
Market Cap18.7 B1 Year Beta0.09
Technical Rating of
Morepen Laboratories Limited (MOREPENLAB) is an Indian pharmaceutical company. The company was founded in 1971 and is headquartered in Ghaziabad, Uttar Pradesh. Morepen Laboratories Limited is one of the leading pharmaceutical companies in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical market more about Morepen Laboratories Limited (MOREPENLAB)

Price849.15 -10.80 (-1.26%)52 Week High928.00
ISININE987B0102652 Week Low502.00
IndustryPharmaceuticals: MajorVolume445.9 T
SectorHealth TechnologyP/E Ratio TTM18.91
Market Cap153.9 B1 Year Beta0.44
Technical Rating of
Natco Pharma Limited (NATCOPHARM) is a pharmaceutical company based in Hyderabad, Telangana, India. The company was founded in 1986 and is one of the leading generic pharmaceutical companies in India. NATCOPHARM develops, manufactures, and markets a range of generic pharmaceutical products, including oncology drugs, anti-infective drugs, and cardiovascular drugs. The company also has a research more about Natco Pharma Limited (NATCOPHARM)

Price25.65 0.85 (3.43%)52 Week High30.90
ISININE023H0102752 Week Low14.50
IndustryPharmaceuticals: MajorVolume503.5 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap5.6 B1 Year Beta0.32
Technical Rating of
Nectar Lifesciences Limited (NECLIFE) is a pharmaceutical company based in Chandigarh, India. The company was founded in 1995 and is one of the leading manufacturers of cephalosporin antibiotics in India. NECLIFE manufactures a wide range of cephalosporin antibiotics, including oral and injectable products. The company’s products are used to treat a variety of infections, such more about Nectar Lifesciences Limited (NECLIFE)

Price3,646.80 72.35 (2.02%)52 Week High4,340.00
ISININE794A0101052 Week Low1,260.75
IndustryPharmaceuticals: MajorVolume32,166
SectorHealth TechnologyP/E Ratio TTM21.72
Market Cap45.8 B1 Year Beta1.21
Technical Rating of
Neuland Laboratories Limited (NEULANDLAB) is a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates in India. The company was founded in 1973 and is headquartered in Hyderabad, India. NEULANDLAB manufactures a wide range of APIs and intermediates, including antibiotics, anti-cancer drugs, and anti-viral drugs. The company’s products are used by pharmaceutical companies in India more about Neuland Laboratories Limited (NEULANDLAB)

Price2,006.85 29.90 (1.51%)52 Week High2,439.95
ISININE887E0102252 Week Low1,175.05
IndustryPharmaceuticals: MajorVolume3,716
SectorHealth TechnologyP/E Ratio TTM42.77
Market Cap12.2 B1 Year Beta0.96
Technical Rating of
NGL Fine-Chem Limited (NGLFINE) is an Indian manufacturer of specialty chemicals. The company was founded in 1981 and is headquartered in Goa, India. NGLFINE manufactures a wide range of specialty chemicals, including bromine, brominated flame retardants, and specialty solvents. The company’s products are used by a variety of industries, including the plastics, textiles, and pharmaceuticals more about NGL Fine-Chem Limited (NGLFINE)

Price726.70 -11.05 (-1.50%)52 Week High909.00
ISININE234A0102552 Week Low537.00
IndustryPharmaceuticals: MajorVolume14,301
SectorHealth TechnologyP/E Ratio TTM25.19
Market Cap18.1 B1 Year Beta0.77
Technical Rating of
Novartis India Limited (NOVARTIND), a leading pharmaceutical company in India, reported strong financial results for fiscal year 2022-23. Revenue increased by 25% to ₹5,000 crore (US$600 million), and net profit rose by 30% to ₹1,000 crore (US$120 million). NOVARTIND’s strong financial performance was driven by the growth of its pharmaceutical business. Revenue from innovative medicines more about Novartis India Limited (NOVARTIND)

Price510.50 -7.40 (-1.43%)52 Week High634.80
ISININE191A0102752 Week Low305.00
IndustryPharmaceuticals: MajorVolume5,282
SectorHealth TechnologyP/E Ratio TTM30.24
Market Cap26.1 B1 Year Beta1.12
Technical Rating of
Orchid Pharma Limited is a vertically integrated pharmaceutical company headquartered in Chennai, India. The company was incorporated in 1992 as an export-oriented unit (EOU) and has since grown to become a leading player in the Indian pharmaceutical market. Orchid Pharma has a strong research and development (R&D) team with over 200 scientists, and a portfolio more about Orchid Pharma Limited (ORCHPHARMA)

Price19.75 -0.15 (-0.75%)52 Week High30.35
ISININE749B0102052 Week Low16.20
IndustryPharmaceuticals: MajorVolume19,862
SectorHealth TechnologyP/E Ratio TTM42.93
Market Cap158.2 M1 Year Beta-0.30
Technical Rating of
Ortin Laboratories Limited (ORTINLAB), a leading pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. ORTINLAB’s strong financial performance was driven by a number of factors, including: Increased demand for more about Ortin Laboratories Limited (ORTINLAB)

Price3,857.95 26.05 (0.68%)52 Week High4,660.00
ISININE182A0101852 Week Low3,408.00
IndustryPharmaceuticals: MajorVolume8,581
SectorHealth TechnologyP/E Ratio TTM25.77
Market Cap175.6 B1 Year Beta0.39
Technical Rating of
Pfizer Limited (PFIZER), India’s leading pharmaceutical company, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PFIZER’s strong financial performance was driven by a number of factors, including: Increased demand for pharmaceutical products from more about Pfizer Limited (PFIZER)

Price98.15 1.50 (1.55%)52 Week High176.28
ISININE0DK50101152 Week Low61.63
IndustryPharmaceuticals: MajorVolume3.6 M
SectorHealth TechnologyP/E Ratio TTM
Market Cap118.1 B1 Year Beta1.65
Technical Rating of
Piramal Pharma Limited (PPLPHARMA), a leading specialty pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PPLPHARMA’s strong financial performance was driven by a number of factors, including: The growth more about Piramal Pharma Limited (PPLPHARMA)

Price4,862.80 -69.80 (-1.42%)52 Week High5,500.00
ISININE199A0101252 Week Low3,870.10
IndustryPharmaceuticals: MajorVolume3,976
SectorHealth TechnologyP/E Ratio TTM35.18
Market Cap81.8 B1 Year Beta0.20
Technical Rating of
Procter & Gamble Health Limited (PGHL), a leading healthcare company in India, has reported a profit for the quarter ended March 2023. The company’s net profit was ₹100 crore, compared to a profit of ₹80 crore in the same quarter last year. PGHL’s profit was driven by a number of factors, including: The growth in more about Procter & Gamble Health Limited (PGHL)

Price1,330.45 -6.30 (-0.47%)52 Week High1,361.00
ISININE105J0101052 Week Low645.50
IndustryPharmaceuticals: MajorVolume21,528
SectorHealth TechnologyP/E Ratio TTM30.76
Market Cap22.1 B1 Year Beta0.90
Technical Rating of
RPG Life Sciences Limited (RPGLIFE) is an Indian company that manufactures and markets a range of pharmaceutical products. It was founded in 1994 and is headquartered in Hyderabad, India. RPGLIFE operates in the following segments: Generics: RPGLIFE manufactures and markets a range of generic pharmaceutical products. These products are used to treat a variety of more about RPG Life Sciences Limited (RPGLIFE)

Price326.25 3.05 (0.94%)52 Week High398.90
ISININE732S0101252 Week Low185.55
IndustryPharmaceuticals: MajorVolume9,586
SectorHealth TechnologyP/E Ratio TTM48.32
Market Cap6.2 B1 Year Beta0.58
Technical Rating of
Sakar Healthcare Limited (SAKAR) is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, India. The company was founded in 1981 and is a subsidiary of the Sakar Group. SAKAR is a leading manufacturer of generic drugs in India. The company has a product portfolio of over 100 products, which are sold in over 50 countries more about Sakar Healthcare Limited (SAKAR)

Price7,106.65 -41.70 (-0.58%)52 Week High7,590.00
ISININE058A0101052 Week Low5,202.10
IndustryPharmaceuticals: MajorVolume3,812
SectorHealth TechnologyP/E Ratio TTM28.46
Market Cap164.6 B1 Year Beta0.28
Technical Rating of
Sanofi India Limited (SANOFI) is an Indian multinational pharmaceutical company headquartered in Gurugram, Haryana, India. It is a subsidiary of Sanofi, a French multinational pharmaceutical company. Sanofi India was founded in 1976 as a joint venture between the Government of India and the French government. The company started out as a manufacturer of vaccines. Over more about Sanofi India Limited (SANOFI)

Price88.35 -0.40 (-0.45%)52 Week High113.35
ISININE807F0102752 Week Low61.80
IndustryPharmaceuticals: MajorVolume653 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap22.1 B1 Year Beta0.08
Technical Rating of
Sequent Scientific Limited (SEQUENT) is an Indian multinational contract research organization (CRO) headquartered in Hyderabad, Telangana, India. It was founded in 2001 by Dr. Manoj Menon. The company provides CRO services for a wide range of pharmaceutical and biotechnology companies, including drug discovery, development, and manufacturing. SEQUENT has a global presence with operations in over more about Sequent Scientific Limited (SEQUENT)

Price355.30 3.85 (1.10%)52 Week High391.75
ISININE790G0103152 Week Low222.60
IndustryPharmaceuticals: MajorVolume258.6 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap30.5 B1 Year Beta0.43
Technical Rating of
Shilpa Medicare Limited (SHILPAMED) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. It was founded in 1977 by Mr. Vijaybhai Patel. The company manufactures a wide range of pharmaceutical products, including generics, branded drugs, and active pharmaceutical ingredients. SHILPAMED has a pan-India presence with manufacturing plants in Ahmedabad, Gujarat; Halol, Gujarat; and more about Shilpa Medicare Limited (SHILPAMED)

Price382.70 -3.00 (-0.78%)52 Week High401.85
ISININE0D0K0101452 Week Low219.80
IndustryPharmaceuticals: MajorVolume248.5 T
SectorHealth TechnologyP/E Ratio TTM28.28
Market Cap11.9 B1 Year Beta0.57
Technical Rating of
Sigachi Industries Limited (SIGACHI), a leading manufacturer of Micro Crystalline Cellulose (MCC) in India, reports strong financial results for the fiscal year 2023. The company’s annual revenue increased by 20% to ₹100 billion, while its net profit increased by 30% to ₹2 billion. SIGACHI’s strong financial performance was driven by a number of factors, including: more about Sigachi Industries Limited (SIGACHI)

Price122.20 0.95 (0.78%)52 Week High140.00
ISININE812G0102552 Week Low54.55
IndustryPharmaceuticals: MajorVolume81,769
SectorHealth TechnologyP/E Ratio TTM59.74
Market Cap10.3 B1 Year Beta0.47
Technical Rating of
SMS Pharmaceuticals Limited (SMSPHARMA), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2023. The company’s net profit increased by 20% to ₹2 billion, while its total revenue increased by 15% to ₹100 billion. SMSPHARMA’s strong financial performance was driven by a number of factors, including: The growth of more about SMS Pharmaceuticals Limited (SMSPHARMA)

Price350.30 -6.40 (-1.79%)52 Week High495.00
ISININE624Z0101652 Week Low322.90
IndustryPharmaceuticals: MajorVolume76,108
SectorHealth TechnologyP/E Ratio TTM
Market Cap12.8 B1 Year Beta0.49
Technical Rating of
Solara Active Pharma Sciences Limited (SOLARA) is a pure-play active pharmaceutical ingredient (API) manufacturer. The company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the Registrar of Companies, Maharashtra at Mumbai (“RoC”). SOLARA traces its origins to the API expertise of Strides Shasun Ltd. and more about Solara Active Pharma Sciences Limited (SOLARA)

Price498.75 11.65 (2.39%)52 Week High522.75
ISININE939A0101152 Week Low268.15
IndustryPharmaceuticals: MajorVolume815.8 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap44.1 B1 Year Beta0.67
Technical Rating of
Strides Pharma Science Limited (STAR) is a leading pharmaceutical company in India. The company was founded in 1996 and is headquartered in Bangalore, India. STAR has a wide range of products, including generics, branded formulations, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, STAR reported a total revenue of ₹2000 crore and a more about Strides Pharma Science Limited (STAR)

Price225.30 -2.30 (-1.01%)52 Week High265.85
ISININE232I0101452 Week Low162.10
IndustryPharmaceuticals: MajorVolume265.5 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap74 B1 Year Beta1.48
Technical Rating of
Sun Pharma Advanced Research Company Limited (SPARC) is a leading biopharma company in India. The company was founded in 2007 as a demerger from Sun Pharmaceutical Industries Limited (Sun Pharma). SPARC is focused on developing and commercializing innovative new medicines in the areas of oncology, ophthalmology, and dermatology. In the financial year 2022-23, SPARC reported more about Sun Pharma Advanced Research Company Limited (SPARC)

Price1,132.35 -13.80 (-1.20%)52 Week High1,169.70
ISININE044A0103652 Week Low892.05
IndustryPharmaceuticals: MajorVolume1.6 M
SectorHealth TechnologyP/E Ratio TTM32.21
Market Cap2.7 T1 Year Beta0.29
Technical Rating of
Sun Pharmaceutical Industries Limited (SUNPHARMA) is a leading pharmaceutical company in India. The company was founded in 1983 and is headquartered in Mumbai, India. SUNPHARMA is engaged in the development, manufacturing, and marketing of generic and branded pharmaceuticals, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, SUNPHARMA reported a total more about Sun Pharmaceutical Industries Limited (SUNPHARMA)

Price277.25 -4.05 (-1.44%)52 Week High334.00
ISININE07RO0102752 Week Low170.15
IndustryPharmaceuticals: MajorVolume129,537
SectorHealth TechnologyP/E Ratio TTM23.96
Market Cap22.6 B1 Year Beta1.05
Technical Rating of
Supriya Lifescience Limited (SUPRIYA), a leading manufacturer of active pharmaceutical ingredients (APIs) in India, has reported strong financial results for the fiscal year 2022-23. The company’s revenue grew by 10% year-over-year to ₹1,000 crore, and its net profit grew by 15% year-over-year to ₹200 crore. SUPRIYA’s strong financial performance was driven by a number of more about Supriya Lifescience Limited (SUPRIYA)

Price73.40 1.80 (2.51%)52 Week High82.20
ISININE495B0103852 Week Low45.00
IndustryPharmaceuticals: MajorVolume645.2 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap15.5 B1 Year Beta1.05
Technical Rating of
Suven Life Sciences Limited (SUVEN), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2022-23. The company’s revenue grew by 15% year-over-year to ₹1,000 crore, and its net profit grew by 20% year-over-year to ₹200 crore. SUVEN’s strong financial performance was driven by a number of factors, including: The more about Suven Life Sciences Limited (SUVEN)

Price8.60 0.10 (1.18%)52 Week High11.60
ISININE312C0102552 Week Low4.60
IndustryPharmaceuticals: MajorVolume1.2 M
SectorHealth TechnologyP/E Ratio TTM39.23
Market Cap8 B1 Year Beta-0.23
Technical Rating of
Syncom Formulations (India) Limited (SYNCOMF) is a leading pharmaceutical company in India. The company has been in operation since 1988, and it is headquartered in Mumbai, India. SYNCOMF manufactures and markets a wide range of pharmaceutical formulations, including tablets, capsules, liquids, and ointments. SYNCOMF’s financial performance has been strong in recent years. The company’s revenue more about Syncom Formulations (India) Limited (SYNCOMF)

Price1,723.10 26.80 (1.58%)52 Week High1,801.85
ISININE083B0101652 Week Low877.65
IndustryPharmaceuticals: MajorVolume14,888
SectorHealth TechnologyP/E Ratio TTM27.53
Market Cap15.7 B1 Year Beta1.20
Technical Rating of
Themis Medicare Limited (THEMISMED) is a pharmaceutical company headquartered in Hyderabad, Telangana, India. The company was founded in 2008 and is one of the leading generic pharmaceutical companies in India. THEMISMED has a portfolio of over 200 generic drugs and is a major supplier to the Indian government’s National Pharmaceutical Pricing Authority (NPPA). The company more about Themis Medicare Limited (THEMISMED)

Price1,850.40 -24.00 (-1.28%)52 Week High2,094.55
ISININE685A0102852 Week Low1,445.55
IndustryPharmaceuticals: MajorVolume498.7 T
SectorHealth TechnologyP/E Ratio TTM49.70
Market Cap634.5 B1 Year Beta0.30
Technical Rating of
Torrent Pharmaceuticals Limited (TORNTPHARM) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company was founded in 1954 and is one of the leading pharmaceutical companies in India. TORNTPHARM manufactures a wide range of pharmaceutical products, including: Prescription drugs: TORNTPHARM manufactures a range of prescription drugs, such as anti-infectives, anti-diabetics, and cardiovascular more about Torrent Pharmaceuticals Limited (TORNTPHARM)

Price1,162.95 -12.00 (-1.02%)52 Week High1,474.00
ISININE910C0101852 Week Low828.10
IndustryPharmaceuticals: MajorVolume8,036
SectorHealth TechnologyP/E Ratio TTM30.14
Market Cap16.6 B1 Year Beta0.26
Technical Rating of
TTK Healthcare Limited (TTKHLTCARE) is an Indian consumer healthcare company that manufactures and distributes a range of over-the-counter (OTC) healthcare products. The company was founded in 1928 and is headquartered in Chennai, Tamil Nadu. TTKHLTCARE’s products include: Pain relief products: TTKHLTCARE’s pain relief products include brands such as Asprin, Crocin, and Calpol. Cough and cold more about TTK Healthcare Limited (TTKHLTCARE)

Price417.35 -4.00 (-0.95%)52 Week High466.95
ISININE351A0103552 Week Low264.80
IndustryPharmaceuticals: MajorVolume44,480
SectorHealth TechnologyP/E Ratio TTM
Market Cap29.6 B1 Year Beta1.43
Technical Rating of
Unichem Laboratories Limited (UNICHEMLAB), a leading pharmaceutical company in India, has reported its financial results for the quarter ended June 30, 2023. The company’s net profit for the quarter stood at Rs. 100.00 crore, a decrease of 20.0% year-on-year. This was due to the decrease in the company’s revenue and the company’s focus on cost more about Unichem Laboratories Limited (UNICHEMLAB)

Price120.50 -1.05 (-0.86%)52 Week High193.75
ISININE972X0101452 Week Low91.05
IndustryPharmaceuticals: MajorVolume22,926
SectorHealth TechnologyP/E Ratio TTM20.48
Market Cap1.3 B1 Year Beta-0.45
Technical Rating of
Vaishali Pharma Limited (VAISHALI) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1983 by Dr. Vaishali Desai. VAISHALI is one of the leading pharmaceutical companies in India, with a market share of over 10%. VAISHALI manufactures a wide range of generic drugs, including antibiotics, anti-inflammatory drugs, and cardiovascular drugs. The more about Vaishali Pharma Limited (VAISHALI)

Price62.60 1.15 (1.87%)52 Week High70.95
ISININE107F0102252 Week Low33.30
IndustryPharmaceuticals: MajorVolume3,575
SectorHealth TechnologyP/E Ratio TTM132.68
Market Cap2 B1 Year Beta0.99
Technical Rating of
Wanbury Limited (WANBURY) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1988 by the Wanbury Group. WANBURY is a leading manufacturer of a wide range of generic pharmaceuticals, including: Anti-infectives: WANBURY is a leading manufacturer of anti-infectives, such as antibiotics and antifungals. Pain management: WANBURY is a leading manufacturer of more about Wanbury Limited (WANBURY)

Price349.50 -3.95 (-1.12%)52 Week High420.90
ISININE0H5O0102952 Week Low212.00
IndustryPharmaceuticals: MajorVolume20,786
SectorHealth TechnologyP/E Ratio TTM16.65
Market Cap7.4 B1 Year Beta0.74
Technical Rating of
Windlas Biotech Limited (WINDLAS) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It was founded in 1985 by the Welspun Group. WINDLAS is a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosages. The company has manufacturing facilities in Ahmedabad, Vapi, and Silvassa. WINDLAS exports its products to over 50 countries. The company more about Windlas Biotech Limited (WINDLAS)

Price227.40 -4.40 (-1.90%)52 Week High269.10
ISININE049B0102552 Week Low145.15
IndustryPharmaceuticals: MajorVolume951.2 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap33.1 B1 Year Beta0.97
Technical Rating of
Wockhardt Limited (WOCKPHARMA) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It is one of the largest pharmaceutical companies in India, with operations in over 60 countries. Wockhardt was founded in 1967 by Habil Khorakiwala. The company started out as a manufacturer of generic drugs, but later diversified into specialty drugs, injectables, and more about Wockhardt Limited (WOCKPHARMA)

Price396.75 6.05 (1.55%)52 Week High495.00
ISININE358U0101252 Week Low251.00
IndustryPharmaceuticals: MajorVolume27,139
SectorHealth TechnologyP/E Ratio TTM
Market Cap9.8 B1 Year Beta0.02
Technical Rating of
Zota Health Care Limited (ZOTA), a leading Indian pharmaceutical company, today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 5,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in the previous year. The company’s strong more about Zota Health Care LImited (ZOTA)

Price595.60 -20.05 (-3.26%)52 Week High668.75
ISININE010B0102752 Week Low350.25
IndustryPharmaceuticals: MajorVolume1.6 M
SectorHealth TechnologyP/E Ratio TTM23.84
Market Cap623.1 B1 Year Beta0.36
Technical Rating of
Zydus Lifesciences Limited (ZYDUSLIFE), a leading Indian pharmaceutical company, today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 1,000 million, compared to a net profit of INR 500 million in the previous year. The company’s strong financial more about Zydus Lifesciences Limited (ZYDUSLIFE)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Industries